Ignite Creation Date:
2025-12-25 @ 4:34 AM
Ignite Modification Date:
2025-12-26 @ 3:36 AM
Study NCT ID:
NCT05429918
Status:
UNKNOWN
Last Update Posted:
2022-06-23
First Post:
2021-07-08
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Ibrutinib Combined With R-CHOP/R-DHAP in Newly Diagnosed Mantle Cell Lymphoma Patients Who Aged ≤65 Years
Sponsor:
Peking University Third Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-30
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-07-08
First Submit QC Date:
None
Study First Post Date:
2022-06-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-20
Last Update Post Date:
2022-06-23
Last Update Post Date Type:
ACTUAL